Myasthenia gravis and pregnancy: retrospective evaluation of 27 pregnancies in a tertiary center and comparison with previous studies

被引:18
作者
Tanacan, Atakan [1 ]
Fadiloglu, Erdem [1 ]
Ozten, Gonca [1 ]
Gunes, Ali Can [1 ]
Orgul, Gokcen [1 ]
Beksac, Mehmet Sinan [1 ]
机构
[1] Hacettepe Univ, Fac Med, Dept Obstet & Gynecol, Div Perinatol, Ankara, Turkey
关键词
Acetylcholine receptors; Myasthenia gravis; Neuromuscular junction; Obstetric complications; Pregnancy; AUTOIMMUNE; CLASSIFICATION; GUIDELINES; MANAGEMENT; DELIVERY; MOTHERS; FETAL;
D O I
10.1007/s11845-019-02029-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and aim To share our experience with the management of pregnancies in women with myasthenia gravis (MG) in a tertiary center. Methods The study retrospectively evaluated 27 pregnancies in 12 patients. The pregnancies were divided into 3 groups on the basis of the clinical course of MG during pregnancy: improvement (n = 7), disease-stable (n = 9), and deterioration (n = 11). The groups were compared with respect to patient characteristics, clinical features, and obstetric outcomes. Results There were 4 miscarriages (14.8%), 3 preterm births (11.1%), and 4 cases of preterm premature rupture of the membranes (PPROM) (14.8%). Exacerbation was observed in 25.9% of the cases; the remission rate during the postpartum period and after miscarriage was 37%. The cesarean section (CS) rate was 78.3%. Pregnancies with deterioration of MG were statistically more likely to have higher miscarriage, preterm birth, PPROM, CS, and transient neonatal MG rates, in addition to a lower gestational age at birth, birth weight, and 5-min Apgar score than pregnancies with improved or stable disease (p values < 0.001, 0.04, 0.03, 0.009, 0.02, < 0.001, 0.002, and 0.043, respectively). Conclusion Physicians who manage pregnant women with MG must be familiar with the clinical features of the condition; a multidisciplinary approach is necessary for a better prognosis.
引用
收藏
页码:1261 / 1267
页数:7
相关论文
共 39 条
[21]  
Massey Janice M, 2014, Continuum (Minneap Minn), V20, P115, DOI 10.1212/01.CON.0000443840.33310.bd
[22]   Clinical features, pathogenesis, and treatment of myasthenia gravis: a supplement to the Guidelines of the German Neurological Society [J].
Melzer, Nico ;
Ruck, Tobias ;
Fuhr, Peter ;
Gold, Ralf ;
Hohlfeld, Reinhard ;
Marx, Alexander ;
Melms, Arthur ;
Tackenberg, Bjoern ;
Schalke, Berthold ;
Schneider-Gold, Christiane ;
Zimprich, Fritz ;
Meuth, Sven G. ;
Wiendl, Heinz .
JOURNAL OF NEUROLOGY, 2016, 263 (08) :1473-1494
[23]  
MITCHELL PJ, 1992, OBSTET GYNECOL, V80, P178
[24]   Does the presence of autoantibodies without autoimmune diseases and hereditary thrombophilia have an effect on recurrent pregnancy loss? [J].
Mumusoglu, Sezcan ;
Beksac, Mehmet Sinan ;
Ekiz, Ali ;
Ozdemir, Pinar ;
Hascelik, Gulsen .
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (14) :2352-2357
[25]   Multivariate determinants of the need for postoperative ventilation in myasthenia gravis [J].
Naguib, M ;
ElDawlatly, AA ;
Ashour, M ;
Bamgboye, EA .
CANADIAN JOURNAL OF ANAESTHESIA-JOURNAL CANADIEN D ANESTHESIE, 1996, 43 (10) :1006-1013
[26]   Myasthenia in pregnancy: best practice guidelines from a UK multispecialty working group [J].
Norwood, Fiona ;
Dhanjal, Mandish ;
Hill, Marguerite ;
James, Natalie ;
Jungbluth, Heinz ;
Kyle, Pippa ;
O'Sullivan, Geraldine ;
Palace, Jacqueline ;
Robb, Stephanie ;
Williamson, Catherine ;
Hilton-Jones, David ;
Nelson-Piercy, Catherine .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (05) :538-543
[27]   Behcet's disease and pregnancy: what to expect? [J].
Orgul, Gokcen ;
Aktoz, Fatih ;
Beksac, Mehmet Sinan .
JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2018, 38 (02) :185-188
[28]  
Orgul G, 2017, CLIN EXP HEPATOL, V3, P212, DOI 10.5114/ceh.2017.71445
[29]   The epidemiology of myasthenia gravis [J].
Phillips, LH .
MYASTHENIA GRAVIS AND RELATED DISORDERS: BIOMCHEMICAL BASIS FOR DISEASE OF THE NEUROMUSCULAR JUNCTION, 2003, 998 :407-412
[30]  
Picone O, 2003, J Gynecol Obstet Biol Reprod (Paris), V32, P654